Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07014462 |
| Title | A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naïve Acute Myeloid Leukemia (AML): DLIT-AML (DLIT-AML) |
| Acronym | DLIT-AML |
| Recruitment | Enrolling by invitation |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | University of Vermont |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |